(Q24245414)

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

A clinical trial of adjunctive oestrogen treatment in women with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

Estrogen - a potential treatment for schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia: a double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

Negative symptoms in schizophrenia. Definition and reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

Gender differences in age at onset of schizophrenia. An overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

Statistics notes. Trials randomised in clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

The neurodevelopmental basis of sex differences in schizophrenia1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

The unit of analysis error in studies about physicians' patient care behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

Issues in the meta-analysis of cluster randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

Prevention of recurrent menstrual psychosis by an oral contraceptive

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

Hormonal influence on the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

Gender and the familial risk for schizophrenia. Disentangling confounding factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

Epidemiology of Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

Gender differences in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

Is the earlier age at onset of schizophrenia in males a confounded finding? Results from a cross-cultural investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

Design fluency: the invention of nonsense drawings after focal cortical lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

Epidemiology of puerperal psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

Oestrogen withdrawal associated psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

Proof of efficacy trials: cross-over versus parallel-group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

Schizophrenia and oestrogens--is there an association?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

Effects of conjugated estrogens on plasma butaperazine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

7 January 2021

Interaction of sex, age, and neuroleptic dose

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

7 January 2021

A Negative Symptom Rating Scale

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

7 January 2021

A clinical trial of the effects of estrogen in acutely psychotic women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

7 January 2021

The neurodevelopmental basis of sex differences in schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

7 January 2021

Extrapyramidal symptoms and oestrogen

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

7 January 2021

The hypothesis of oestrogen withdrawal associated psychoses and the paradox of antipsychotic drug-induced hypoestrogenaemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

7 January 2021

Depo-medroxy progesterone acetate as an adjunctive treatment in three aggressive schizophrenic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

7 January 2021

Oestrogen withdrawal associated psychoses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

7 January 2021

Estrogens in Tardive Dyskinesia in Male Psychiatric Patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

7 January 2021

Estrogen treatment of dyskinetic disorders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004719.PUB2

7 January 2021